A novel cause of DKC1‐related bone marrow failure: Partial deletion of the 3′ untranslated region

Telomere biology disorders (TBDs), including dyskeratosis congenita (DC), are a group of rare inherited diseases characterized by very short telomeres. Mutations in the components of the enzyme telomerase can lead to insufficient telomere maintenance in hematopoietic stem cells, resulting in the bone marrow failure that is characteristic of these disorders. While an increasing number of genes are being linked to TBDs, the causative mutation remains unidentified in 30‐40% of patients with DC. There is therefore a need for whole genome sequencing (WGS) in these families to identify novel genes, or mutations in regulatory regions of known disease‐causing genes. Here we describe a family in which a partial deletion of the 3′ untranslated region (3′ UTR) of DKC1, encoding the protein dyskerin, was identified by WGS, despite being missed by whole exome sequencing. The deletion segregated with disease across the family and resulted in reduced levels of DKC1 mRNA in the proband. We demonstrate that the DKC1 3′ UTR contains two polyadenylation signals, both of which were removed by this deletion, likely causing mRNA instability. Consistent with the major function of dyskerin in stabilization of the RNA subunit of telomerase, hTR, the level of hTR was also reduced in the proband, providing a molecular basis for his very short telomeres. This study demonstrates that the terminal region of the 3′ UTR of the DKC1 gene is essential for gene function and illustrates the importance of analyzing regulatory regions of the genome for molecular diagnosis of inherited disease.

[1]  S. Savage,et al.  Germline mutation of MDM4, a major p53 regulator, in a familial syndrome of defective telomere maintenance , 2020, Science Advances.

[2]  J. Shay,et al.  Telomeres and telomerase: three decades of progress , 2019, Nature Reviews Genetics.

[3]  S. Savage Beginning at the ends: telomeres and human disease , 2018, F1000Research.

[4]  J. Benítez,et al.  Mutations in XLF/NHEJ1/Cernunnos gene results in downregulation of telomerase genes expression and telomere shortening , 2017, Human molecular genetics.

[5]  Grace X. Y. Zheng,et al.  Massively parallel digital transcriptional profiling of single cells , 2016, Nature Communications.

[6]  R. Reddel,et al.  The wide‐ranging clinical implications of the short telomere syndromes , 2016, Internal medicine journal.

[7]  Alberto Angrisani,et al.  Human dyskerin: beyond telomeres , 2014, Biological chemistry.

[8]  Jiang Li,et al.  Finding the lost treasures in exome sequencing data. , 2013, Trends in genetics : TIG.

[9]  Semyon Kruglyak,et al.  Isaac: ultra-fast whole-genome secondary analysis on Illumina sequencing platforms , 2013, Bioinform..

[10]  R. Cawthon,et al.  Short telomere length, cancer survival, and cancer risk in 47102 individuals. , 2013, Journal of the National Cancer Institute.

[11]  Sue Fletcher,et al.  Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements , 2012, Cellular and Molecular Life Sciences.

[12]  S. Savage,et al.  The accumulation and not the specific activity of telomerase ribonucleoprotein determines telomere maintenance deficiency in X-linked dyskeratosis congenita. , 2012, Human molecular genetics.

[13]  E. Wahle,et al.  Control of poly(A) tail length , 2011, Wiley interdisciplinary reviews. RNA.

[14]  S. Savage,et al.  The genetics and clinical manifestations of telomere biology disorders , 2010, Genetics in Medicine.

[15]  Richard M. Cawthon,et al.  Telomere length measurement by a novel monochrome multiplex quantitative PCR method , 2009, Nucleic acids research.

[16]  Xiaodong Qi,et al.  The Telomerase Database , 2007, Nucleic Acids Res..

[17]  K. Collins,et al.  Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation. , 2007, Molecular cell.

[18]  S. Chanock,et al.  Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. , 2007, Blood.

[19]  N. Bache,et al.  Protein Composition of Catalytically Active Human Telomerase from Immortal Cells , 2007, Science.

[20]  E. Hiyama,et al.  Telomere and telomerase in stem cells , 2007, British Journal of Cancer.

[21]  K. Collins,et al.  Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita. , 2006, Genes & development.

[22]  S. Kulkarni,et al.  Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita. , 2005, Blood.

[23]  K. Collins,et al.  Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita , 2004, Human Genetics.

[24]  E. Hoffman,et al.  Detection of Nonrandom X Chromosome Inactivation , 2002, Current protocols in human genetics.

[25]  T. Vulliamy,et al.  Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice , 2002, Oncogene.

[26]  E. Stevens-Linders,et al.  Acquired skewing of Lyonization remains stable for a prolonged period in healthy blood donors , 2002, Leukemia.

[27]  T. Vulliamy,et al.  Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. , 2001, Blood cells, molecules & diseases.

[28]  K. Collins,et al.  A telomerase component is defective in the human disease dyskeratosis congenita , 1999, Nature.

[29]  A. Poustka,et al.  Dyskeratosis Congenita Caused by a 3′ Deletion: Germline and Somatic Mosaicism in a Female Carrier , 1999 .

[30]  A. Poustka,et al.  X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. , 1999, American journal of human genetics.

[31]  Jing Zhao,et al.  Formation of mRNA 3′ Ends in Eukaryotes: Mechanism, Regulation, and Interrelationships with Other Steps in mRNA Synthesis , 1999, Microbiology and Molecular Biology Reviews.

[32]  S. Klauck,et al.  X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions , 1998, Nature Genetics.

[33]  T. Vulliamy,et al.  Skewed X-inactivation in carriers of X-linked dyskeratosis congenita. , 1997, Blood.

[34]  A. Ferraris,et al.  Nonrandom X-chromosome inactivation in hemopoietic cells from carriers of dyskeratosis congenita. , 1997, American journal of human genetics.

[35]  K. Devriendt,et al.  Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita. , 1997, American journal of human genetics.

[36]  G. Church,et al.  The genomic sequencing technique. , 1985, Progress in clinical and biological research.